Today announced its development support part in the newly launched Vaccines norge.

Aquilent launches new vaccine federal government site to greatly help citizens stay healthy Aquilent, the recognized leading provider of Web-based solutions shaping the next generation of technology for the government, today announced its development support part in the newly launched site, under contract with the U norge .S. Department of Health insurance and Human Providers . Relating to a press release issued by HHS,, which promotes YOUR VERY BEST Shot at Good Wellness, is the initial cross-government website specialized in providing consumer information regarding vaccines and immunization, combining expertise and articles from agencies across the Department.

.. Arcion reports top-line outcomes from ARC-4558 Phase 2b clinical trial for painful diabetic neuropathy Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, announced top-line outcomes from a successful Phase 2b double-blind today, randomized, placebo-controlled clinical trial of its business lead topical pain applicant, ARC-4558, in adult sufferers with painful diabetic neuropathy . ARC-4558 is certainly a 0.1 percent gel formulation of clonidine hydrochloride for topical administration. The study results successfully demonstrated therapeutic prospect of dealing with PDN with ARC-4558 by targeting irregular nerve signaling at the amount of your skin with a 0.1 percent topical gel formulation of clonidine.05).

Related Articles

Other Articles from "care":